Veeva Systems Introduces Falcon Platform for Agentic Labor in Drug Development
Veeva Systems announced in a press release the launch of Veeva Falcon, an agentic platform and a set of standard agents aimed at improving efficiency across major drug development processes. Falcon integrates with Veeva Development Cloud applications to reduce costs, increase speed, and maintain compliance for biopharmaceutical companies of various sizes.
The platform focuses initially on three areas: trial master file document intake and quality control, health authority correspondence in regulatory operations, and safety case triage and intake. These functions are designed to streamline workflows within clinical, regulatory, and safety domains.
Veeva Falcon represents the company’s first offering in agentic labor, with early adopter availability planned for November 2026. The system is part of Veeva AI, a suite of AI solutions that support industry-specific automation for life sciences organizations.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Sales & Marketing AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 BOC Group Adds AI Assistant to ADOIT 21 Oct 16 Huawei Brings Upgraded Stellar Network Solution to Europe Oct 16 Element to Manage Waymo's Toronto Fleet for 2028 Launch Oct 16 CTM and Huawei Plan AI Network Security Upgrades in Macao Oct 16 Huawei and 14 partners form Global AI CITY allianceEnterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Veeva Introduces AI Agent for Clinical Study Configuration
Amgen Selects Veeva Vault CRM for Global Deployment
AbbVie Partners With Valkai on AI Tools for Clinical Development
Servier Adopts Veeva OpenData Across More Than 80 Countries
Suvoda Updates Clinical Trial Platform With AI and Unified Access
Daily AI Brief: the AI news that matters, in your inbox.